Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
IMPORTANT SAFETY INFORMATION: GLP-1 Receptor Agonists All GLP-1 receptor agonists (e.g., Tirzepatide, Semaglutide, Liraglutide) carry important safety considerations regarding potential serious adverse reactions, including the risk of thyroid C-cell tumors, pancreatitis, gallbladder disease, and severe gastrointestinal reactions
Still in global late-stage clinical trials pending FDA approval
Even if you emphasize starting with a higher dose, your doctor will not prescribe you 1.7 mg or 2.4 mg of Wegovy right away
10.1016/j.biopha.2022.113096 144 ZhouY.YangJ.ChenC.LiZ.ChenY.ZhangX.et al (2021)
And equally as important, how do we help them sustain progress after stopping
Theyll likely need to adapt pricing, marketing, and real-world evidence strategies to continue pushing payers toward coverage
US$ 29.56
US$ 23.97
US$ 22.42
US$ 25.83
